Funding for this research was provided by:
Text and Data Mining valid from 2019-09-05
Received: 9 April 2019
Accepted: 7 August 2019
First Online: 5 September 2019
Ethics approval and consent to participate
: All patients gave written informed consent for participation. This study was approved by the National Cancer Institute Institutional Review Board. The trial national registration number is NCT02536469.
: Not applicable.
: All National Cancer Institute authors declare that they have no competing interests.Dr. Heery is an employee of Precision Biosciences and has no financial relationship with BMS or this product.No writing assistance was utilized in the production of this manuscript.